What are Peptides?

Peptides are one of the most significant scientific discoveries in modern medicine — and they are transforming the way we approach health, prevention, and the extension of active longevity. These small but powerful molecules play a vital role in optimizing the body's functions, enhancing quality of life, and supporting healthy aging for years to come.

Today, peptide bioregulators are gaining widespread recognition across Europe as a science-backed approach to preventive health — and the research behind them spans over five decades of clinical investigation.

A Brief History of Discovery

The story of peptides begins in 1900, when German organic chemist Emil Fischer first proposed that they consist of chains of amino acids linked by specific chemical bonds. By 1902, the existence of stable peptide bonds had been scientifically confirmed, laying the groundwork for one of the most important fields in modern biochemistry.

For decades, scientists worked to understand the precise role peptides play in the human body. The most significant breakthrough came in the 1960s, during classified research conducted at the Military Medical Academy.

There, a scientific team led by Professor Vladimir Khavinson and Morozov identified — for the first time — the specific functions of numerous amino acid sequences and developed pioneering methods for their synthesis and industrial production.

This foundational work gave rise to what we now know as Khavinson peptides (also referred to as Havinson peptides) — a system of tissue-specific peptide bioregulators that has since become the basis for an entirely new approach to cellular health and longevity.

What Exactly are Peptides?

At their core, peptides are short chains of amino acids — the same building blocks that make up proteins. They are synthesized in all living organisms and act as biological regulators, directing key cellular processes including tissue repair, cell regeneration, immune response, and metabolic function.

In groundbreaking research, special peptides were isolated from the organs of young animals. These peptides demonstrated a remarkable ability: to restore and maintain optimal cellular metabolism — effectively signaling aging or damaged cells to function as they once did.

This discovery became the scientific foundation for peptide bioregulators as we know them today — and it remains the core of every product available in the IPEPT Europe store.

Peptide Bioregulators vs. Conventional Drugs: What's the Difference?

Unlike conventional pharmaceuticals, peptide bioregulators do not force the body into a fixed response. Their defining property is regulatory action: they stimulate cellular functions when those functions are suppressed — and reduce activity when it exceeds healthy levels. This intelligent, bidirectional mechanism sets them apart from any drug class available today.

This unique property led to the development of an entirely new category of health compounds: peptide bioregulators and geroprotectors — a field pioneered by Professor Vladimir Khavinson and now widely studied across Europe and internationally.

As we age — or when pathologies develop — the body's natural peptide synthesis declines. This disruption leads to cellular damage, organ deterioration, and accelerated biological aging. Peptide bioregulators act as precise biological signals, reactivating the cellular functions that have been lost or suppressed. Think of them as information keys: each one designed for a specific lock, in a specific organ.

A deficiency in peptides is directly linked to premature aging of tissues. The earlier the body receives targeted peptide support, the greater the potential to preserve health, vitality, and function for decades to come.

Each peptide bioregulator has a specific function — and every organ requires its own.
Explore our full catalog to find the right peptides for your health goals.

How Khavinson Peptides Were Developed

In the early 1990s, the military research program was discontinued. Rather than abandon decades of groundbreaking work, the lead scientists — under the direction of Professor Vladimir Khavinson — continued their research at the newly established Institute of Bioregulation and Gerontology.

What followed was more than thirty years of systematic clinical investigation. The result: a comprehensive system of peptide bioregulators — and later, a line of bioavailable food supplements based on them — which are now available to customers across Europe through the IPEPT store.

Among the most significant findings from this period:

Inclusion of peptides in the diet of experimental mice increased their lifespan by 30–38%
Research conducted at the Kyiv Institute of Gerontology demonstrated a nearly twofold reduction in human mortality among participants using peptide supplementation — one of the most compelling demonstrations of their geroprotective potential
Following extensive laboratory validation, these supplements entered mass production in 2010 and have since been used by hundreds of thousands of people worldwide

International Recognition and Clinical Evidence

The discovery of peptide bioregulators has been compared in significance to the launch of the first satellite — a turning point not just for a single field, but for our entire understanding of biological aging.

Over 40 independent experiments have consistently confirmed a central finding: aging, and many chronic diseases including cancer, are rooted in the disruption of protein synthesis regulation. When this regulation fails, metabolic processes break down — and pathologies follow.

Key experimental findings include:

In cell culture studies, different peptide preparations triggered the growth of corresponding tissues — liver peptides stimulated liver tissue, thymus peptides activated immune cells — demonstrating extraordinary organ specificity
Scientists were able to surpass the Hayflick limit (normally capped at ~47 cell divisions): introduction of the epiphysis peptide extended cell divisions to 64 — a 42% increase beyond the theoretical biological ceiling
These results were independently verified five times in Geneva, under the supervision of an international scientific panel

Annual courses combining peptides from the epiphysis, thymus, brain, blood vessels, liver, cartilage, thyroid, and pancreas
produced measurable, reproducible improvements — including:

Enhanced immune and neuroendocrine function
Improved cardiovascular performance
Better cognitive function and brain health
Increased bone and cartilage density
And critically — a nearly twofold reduction in mortality

This is not marginal improvement. This is a fundamentally different approach to aging — and it is the scientific foundation behind
every Khavinson peptide product available at IPEPT Europe.

The 5th Generation: Lingual Peptide Geroprotectors

Peptide science continues to evolve. Today, researchers have developed the fifth generation of complex peptide geroprotectors — known as linguals. These are liquid-form formulations that deliver active peptide compounds directly into the bloodstream, bypassing the gastrointestinal tract entirely. The result is faster absorption, higher bioavailability, and greater effectiveness — representing the most advanced delivery system available in peptide bioregulation to date.

The primary goal of these next-generation formulations remains the same as the research that inspired them: to maintain optimal cellular health and meaningfully slow the biological aging process.

Peptide bioregulators are among the most effective tools available for revitalization, cellular rejuvenation, and long-term disease prevention — including protection against oncological conditions. While supplementation can begin as early as age 25–30, it becomes especially important for individuals aged 40 and above, when the body's natural peptide synthesis begins to decline most noticeably.

This approach works at the deepest level — renewing the body cellularly, synchronizing biological cycles, and enhancing the capacity for healthy cell division without increasing the risk of mutations.

Clinical Results: What the Evidence Shows

The long-term clinical record of Havinson peptide bioregulators is extensive and consistent. Over several decades, more than 15 million people across various health conditions have used these preparations — with an average reported effectiveness rate exceeding 85%. Crucially, across all this use, no significant side effects have been recorded. This safety profile is not incidental — it reflects the fundamental nature of peptides as molecules the body already recognizes and uses.

For adults aged 25 to 60, just a few targeted courses per year are sufficient to maintain essential biological functions and significantly slow premature aging. Even in otherwise healthy individuals, the gradual involution of key systems — immune, neuroendocrine, and central nervous — begins with age and accelerates under environmental stress. Peptide bioregulators address this decline at its source, before symptoms appear.

This is precisely why preventive use matters. The earlier you begin supporting your body with a structured peptide program, the more pronounced and lasting the results will be.

Why Peptide Bioregulation Works

What makes peptide bioregulators genuinely unique is their ability to work with the body rather than override it. They regulate cellular activity using mechanisms that are native to human biology — mechanisms we are born with. Rather than introducing foreign signals, they restore the body's own language of cellular communication.

For those managing health conditions, this means restoring normal cell function, slowing degenerative processes, and directing biological resources toward tissue repair. For healthy individuals, it means keeping the immune system operating at peak capacity and slowing organ aging — even if that process has already begun.

The outcome is the same in both cases: a longer period of active, healthy, fully engaged living — independent of chronological age. Peptide bioregulation is one of the safest and most evidence-based strategies available for extending biological youth. There is no risk of overdose, no known contraindications, and no side effects. It simply activates what your body already knows how to do — and gives it the tools to do it better, for longer.

Ready to Start?

For a deeper look at how to use peptide bioregulators, what to expect, and real customer experiences — visit our blog.
Or connect with one of our specialists directly via live chat for a personalized peptide consultation tailored to your health goals.

Your biology has the capacity to renew itself. Khavinson peptides give it the signal to begin.